Aquilo Capital Management, LLC Xenon Pharmaceuticals Inc. Transaction History

Aquilo Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$10.21 - $14.9 $15.3 Million - $22.3 Million	-1,499,970 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$8.08 - $17.57 $2.69 Million - $5.85 Million	333,234 Added 28.56%	1,499,970 $17 Million
Q4 2019 Feb 14, 2020	BUY	$8.11 - $14.65 $1.75 Million - $3.15 Million	215,209 Added 22.62%	1,166,736 $15.3 Million
Q4 2018 Feb 14, 2019	BUY	$5.61 - $12.62 $2.01 Million - $4.53 Million	358,725 Added 60.51%	951,527 $6 Million
Q3 2018 Nov 14, 2018	BUY	$9.0 - $14.9 $5.34 Million - $8.83 Million	592,802 New	592,802 $7.83 Million

212

70.2M

88.3K

28.8K

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.42B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

Get notified when there are updates to the investment portfolio of Aquilo Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Aquilo Capital Management, LLC with notifications on news.